GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolase Inc (FRA:BTH0) » Definitions » Cyclically Adjusted PB Ratio

Biolase (FRA:BTH0) Cyclically Adjusted PB Ratio : 0.00 (As of May. 14, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Biolase Cyclically Adjusted PB Ratio?

As of today (2024-05-14), Biolase's current share price is €0.1418. Biolase's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €2,459.45. Biolase's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for Biolase's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, Biolase's highest Cyclically Adjusted PB Ratio was 5.61. The lowest was 0.01. And the median was 1.34.

FRA:BTH0's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.19
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biolase's adjusted book value per share data for the three months ended in Dec. 2023 was €-0.066. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2,459.45 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biolase Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biolase's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolase Cyclically Adjusted PB Ratio Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.41 0.30 0.30 0.02 -

Biolase Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 - - -

Competitive Comparison of Biolase's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Biolase's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolase's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biolase's Cyclically Adjusted PB Ratio falls into.



Biolase Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biolase's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1418/2459.45
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolase's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Biolase's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.066/129.4194*129.4194
=-0.066

Current CPI (Dec. 2023) = 129.4194.

Biolase Quarterly Data

Book Value per Share CPI Adj_Book
201403 2,028.349 99.695 2,633.121
201406 665.732 100.560 856.793
201409 2,302.941 100.428 2,967.756
201412 6,890.303 99.070 9,001.126
201503 6,916.532 99.621 8,985.380
201506 5,578.629 100.684 7,170.787
201509 4,732.460 100.392 6,100.837
201512 4,613.105 99.792 5,982.673
201603 3,909.476 100.470 5,035.931
201606 3,400.605 101.688 4,327.982
201609 4,031.076 101.861 5,121.680
201612 3,631.597 101.863 4,614.045
201703 2,976.083 102.862 3,744.455
201706 3,475.463 103.349 4,352.165
201709 2,740.278 104.136 3,405.609
201712 3,018.926 104.011 3,756.403
201803 2,469.353 105.290 3,035.271
201806 2,118.204 106.317 2,578.489
201809 1,694.915 106.507 2,059.541
201812 1,156.228 105.998 1,411.710
201903 724.296 107.251 874.009
201906 383.543 108.070 459.315
201909 -110.251 108.329 -131.715
201912 26.948 108.420 32.167
202003 -348.533 108.902 -414.199
202006 57.696 108.767 68.651
202009 312.876 109.815 368.732
202012 208.498 109.897 245.537
202103 470.678 111.754 545.078
202106 455.903 114.631 514.717
202109 419.915 115.734 469.568
202112 362.437 117.630 398.764
202203 302.964 121.301 323.241
202206 298.293 125.017 308.798
202209 195.982 125.227 202.544
202212 59.772 125.222 61.776
202303 28.944 127.348 29.415
202306 5.999 128.729 6.031
202309 0.137 129.860 0.137
202312 -0.066 129.419 -0.066

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biolase  (FRA:BTH0) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biolase Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biolase's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolase (FRA:BTH0) Business Description

Traded in Other Exchanges
Address
27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

Biolase (FRA:BTH0) Headlines

No Headlines